Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging azithromycin resistance for guiding treatment, guidelines and breakpoints | Zendy

Jeremy D. Brown | Zendy; Simon J Willcox | Zendy; Neil Franklin | Zendy; Briony Hazelton | Zendy; Peter Howard | Zendy; Tracie Reinten | Zendy; Vicky Sheppeard | Zendy; Matthew O’Sullivan | Zendy

Open Access

Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging azithromycin resistance for guiding treatment, guidelines and breakpoints

Author(s) -

Jeremy D. Brown,

Simon J Willcox,

Neil Franklin,

Briony Hazelton,

Peter Howard,

Tracie Reinten,

Vicky Sheppeard,

Matthew O’Sullivan

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx268

Subject(s) - azithromycin , shigella , epidemiology , antimicrobial , antibiotic resistance , microbiology and biotechnology , medicine , biology , antibiotics , bacteria , salmonella , genetics

To examine antimicrobial susceptibility patterns and predictors of resistance among Shigella isolates in New South Wales (NSW), Australia during 2013-14 with emphasis on azithromycin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research